1 day ago · Pfizer delivered strong fourth quarter and full-year 2024 financial results, demonstrating the company’s continued focus on commercial execution. Full-year 2024 …

1 day ago · NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) reported financial results for fourth-quarter and full-year 2024 and reaffirmed its 2025 financial guidance (5) provided on …

22 hours ago · Pfizer reported $63.6 billion in revenue for the full year, up 7% compared to 2023. The full-year revenue beat Wall Street consensus estimates of $62.9 billion, and earnings per …

22 hours ago · On Tuesday, Pfizer Inc. (NYSE:PFE) reported fourth-quarter adjusted EPS of 63 cents, compared to 10 cents a year ago, beating the consensus of 47 cents. The U.S. …

23 hours ago · Global pharmaceutical company Pfizer (NYSE:PFE) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 21.9% year on year to $17.76 billion. …

1 day ago · Pfizer reported robust fourth-quarter 2024 earnings, ... Pfizer Beats Q4 Revenue, EPS Estimates. By JesterAI – Feb 4, 2025 at 9:35AM Key Points. Pfizer's adjusted EPS of $0.63 …

1 day ago · Reports Q4 revenue $17.8B, consensus $17.26B. Dr. Albert Bourla, Chairman and Chief Executive Officer, stated: “2024 was a strong year of execution and performance for …

23 hours ago · Related: Pfizer stock climbs on Q4 revenue and earnings beat, reaffirmed guidance . The company said it is on track to deliver approximately $4.5 billion in overall net …

1 day ago · The results cap off a critical year for Pfizer, which has been slashing costs as it recovers from the rapid decline of its Covid business and stock price.

1 day ago · Excluding items, Pfizer Inc. reported adjusted earnings of $3.592 billion or $0.63 per share for the period. Analysts projected $0.46 per share Revenue: $17.763 billion in Q4 vs. …